Preliminary investigation of potential links between pigmentation variants and opioid analgesic effectiveness in horses during cerebrospinal fluid centesis.

Summary

# Editorial Summary Opioid analgesics show considerable individual variation in effectiveness across the equine population, a challenge that has prompted investigation into genetic factors that might explain these differences. Researchers examined whether variants in genes controlling coat colour—specifically the melanocortin-1-receptor (MC1R) gene and its interaction with the agouti signalling protein (ASIP) gene—correlate with analgesic response during cerebrospinal fluid centesis, scoring pain responses on a three-point scale following sedation and dural puncture. The melanocortin system's known involvement in opioid receptor function in other species provided the biological rationale, though this relationship had not previously been characterised in horses. Whilst this preliminary investigation represents early-stage work in a small population, a positive association between pigmentation genotypes and analgesic efficacy could eventually allow practitioners to anticipate variable drug responses and refine sedation protocols accordingly. Given the known challenges in predicting individual opioid effectiveness in equine practice, understanding whether coat colour genetics offers any predictive value warrants further investigation with larger sample sizes and validation across different procedures and pain states.

Read the full abstract on PubMed

Key Findings

• •MC1R gene variants show potential association with opioid analgesic response during CSF centesis procedures
• •Pigmentation phenotype, controlled by MC1R and ASIP gene interaction, may influence individual variation in opioid effectiveness
• •Melanocortin system pleiotropic effects warrant further investigation as a mechanism explaining inter-individual differences in equine opioid response

Conditions Studied

Tags